Data / Form D filings / Phase Genomics, Inc.
Phase Genomics, Inc.: Form D filings
Phase Genomics, Inc., a biotechnology company in Seattle, WA, filed 2 Form D notices with the SEC between 2017 and 2023. The latest, on March 21, 2023, reports $4.8 million sold of a $6.6 million offering to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1617 8th Ave. North, Seattle, WA, 98109
- Phone
- (206) 384-6228
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1722760
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 21, 2023 | New notice | $6,579,358 | $4,754,364 | $1,824,994 | 13 | Mar 14, 2023 | sec.gov |
| Nov 22, 2017 | New notice | $1,400,000 | $1,000,001 | $399,999 | 4 | Nov 9, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Shawn Sullivan | Executive Officer, Promoter | |
| Ivan Liachko | Executive Officer, Director, Promoter | |
| Kayla Young | Executive Officer |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
Every Form D from the week of Mar 20, 2023 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Phase Genomics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.